Introducing a new TRK/ROS1 inhibitor: Explore a new treatment option for NTRK fusion-positive solid tumors and ROS1+ mNSCLC

Managed Care News and Research: Quarter 1 2019

< Back to Resources

For more than 20 years, The American Journal of Managed Care® (AJMC®) has been the leading peer-reviewed journal dedicated to issues in managed care, disseminating clinical information to managed care physicians, clinical decision-makers, and other healthcare professionals. As the managed care landscape has evolved over the past two decades, AJMC® has been a consistent presence for professionals, expanding to digital platforms and means of delivering the latest Managed Care News and Research. Access leading information pertinent to your business with AJMC®